Sage Journals: Discover world-class research

Retricted access

Case report

First published 2022-4

Cerebral Venous Sinus Thrombosis due to Thrombosis with Thrombocytopenia Syndrome Following Ad26.COV2.S: A First Real-World Case Report of a Male Subject

Samia Asif, Meghana Kesireddy, Scott A. Koepsell [...]

The Neurohospitalist

Open access

Review article

First published 2021

Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review

Usama Waqar, Shaheer Ahmed, Syed M.H.Ali Gardezi [...]

Clinical and Applied Thrombosis/Hemostasis

Open access

Research article

First published 2023

Demonstration of Antibodies Against SARS-CoV-2,Neutralizing or Binding,in Seroconversion Panels After mRNA-1273,BNT-162b2,and Ad26.COV2.S Vaccine Administration

Francisco Belda, Oscar Mora, Monica Lopez-Martinez [...]

Blood & Plasma

Open access

Research article

First published 2023-10

Humoral immune response after Ad26.COV2.S vaccination in patients with multiple sclerosis treated with natalizumab

Mark Gudesblatt, Myassar Zarif, Barbara Bumstead [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Case report

First published 2022-6

A probable case of vaccine-induced immune thrombotic thrombocytopenia secondary to Pfizer Comirnaty COVID-19 vaccine

Carol Goh CY, Chew Teng Keat, Chiang Su Kien [...]

Journal of the Royal College of Physicians of Edinburgh

Open access

Research article

First published 2022

Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer

Elyssa Denault, Erika Nakajima, Vivek Naranbhai [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2024

Determinants of COVID-19 vaccine-induced myocarditis

Jessica Rose, Nicolas Hulscher, Peter A. McCullough

Therapeutic Advances in Drug Safety

Search results

Cerebral Venous Sinus Thrombosis due to Thrombosis with Thrombocytopenia Syndrome Following Ad26.COV2.S: A First Real-World Case Report of a Male Subject

Thrombosis with Thrombocytopenia Syndrome After Administration of AZD1222 or Ad26.COV2.S Vaccine for COVID-19: A Systematic Review

Demonstration of Antibodies Against SARS-CoV-2,Neutralizing or Binding,in Seroconversion Panels After mRNA-1273,BNT-162b2,and Ad26.COV2.S Vaccine Administration

Humoral immune response after Ad26.COV2.S vaccination in patients with multiple sclerosis treated with natalizumab

A probable case of vaccine-induced immune thrombotic thrombocytopenia secondary to Pfizer Comirnaty COVID-19 vaccine

Immunogenicity of SARS-CoV-2 vaccines in patients with breast cancer

Determinants of COVID-19 vaccine-induced myocarditis